17-58308656-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000343736.9(TSPOAP1):c.4616C>T(p.Pro1539Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000145 in 1,609,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000092 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00015 ( 0 hom. )
Consequence
TSPOAP1
ENST00000343736.9 missense
ENST00000343736.9 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 5.05
Genes affected
TSPOAP1 (HGNC:16831): (TSPO associated protein 1) Enables benzodiazepine receptor binding activity. Predicted to be involved in regulation of presynaptic cytosolic calcium ion concentration. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.095044255).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPOAP1 | NM_004758.4 | c.4616C>T | p.Pro1539Leu | missense_variant | 22/32 | ENST00000343736.9 | NP_004749.2 | |
TSPOAP1 | NM_001261835.2 | c.4616C>T | p.Pro1539Leu | missense_variant | 22/32 | NP_001248764.1 | ||
TSPOAP1 | NM_024418.3 | c.4436C>T | p.Pro1479Leu | missense_variant | 21/31 | NP_077729.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPOAP1 | ENST00000343736.9 | c.4616C>T | p.Pro1539Leu | missense_variant | 22/32 | 1 | NM_004758.4 | ENSP00000345824 | P2 | |
TSPOAP1 | ENST00000268893.10 | c.4436C>T | p.Pro1479Leu | missense_variant | 21/31 | 1 | ENSP00000268893 | A2 | ||
TSPOAP1 | ENST00000580669.6 | c.2012C>T | p.Pro671Leu | missense_variant | 6/16 | 5 | ENSP00000462822 | |||
TSPOAP1 | ENST00000582679.1 | c.422-715C>T | intron_variant | 5 | ENSP00000462710 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152238Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
14
AN:
152238
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000645 AC: 16AN: 247900Hom.: 0 AF XY: 0.0000817 AC XY: 11AN XY: 134700
GnomAD3 exomes
AF:
AC:
16
AN:
247900
Hom.:
AF XY:
AC XY:
11
AN XY:
134700
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000150 AC: 219AN: 1457702Hom.: 0 Cov.: 31 AF XY: 0.000138 AC XY: 100AN XY: 724588
GnomAD4 exome
AF:
AC:
219
AN:
1457702
Hom.:
Cov.:
31
AF XY:
AC XY:
100
AN XY:
724588
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152238Hom.: 0 Cov.: 34 AF XY: 0.000108 AC XY: 8AN XY: 74380
GnomAD4 genome
AF:
AC:
14
AN:
152238
Hom.:
Cov.:
34
AF XY:
AC XY:
8
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
14
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.4616C>T (p.P1539L) alteration is located in exon 22 (coding exon 22) of the TSPOAP1 gene. This alteration results from a C to T substitution at nucleotide position 4616, causing the proline (P) at amino acid position 1539 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;M
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N
REVEL
Benign
Sift
Uncertain
D;.;D
Sift4G
Uncertain
T;.;T
Polyphen
B;.;B
Vest4
MVP
MPC
0.25
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at